InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (INFU) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
infu · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for InfuSystem Holdings, Inc. (INFU) measures how much investors pay for each dollar of the company's trailing earnings. INFU's current PE ratio of 23.07x is calculated by dividing its stock price of $9.03 by its TTM earnings per share of $0.39. −98.9% discount vs 5Y avg 2112.4x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 12 fiscal years · Front-end computedMinQ1 · 25%40.5x
MedianQ3 · 75%9957.3x
Max
At 23.07x, INFU's current P/E is within its average historical range over the past 12 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
InfuSystem Holdings, Inc.You INFU | $182M | 23.07x | — | $0.39 |
 Electromed, Inc. ELMD | $307M | 24.32x | — | $0.90 |
 Solana Company HSDT | $80M | N/A | — | -$1.85 |
 Inventiva S.A. IVA | $203M | N/A | — | -$1.82 |
 KORU Medical Systems, Inc. KRMD | $184M | N/A | — | -$0.06 |
 Nano-X Imaging Ltd. NNOX | $129M | N/A | — | -$1.16 |
 Nyxoah S.A. NYXH | $55M | N/A | — | -$2.36 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 27.96x | $0.32 | -63.5% | |
2024-12-31 FY2024 | 76.65x | $0.11 | -69.8% | |
2023-12-31 FY2023 | 254.12x | $0.04 | -97.4% | |
2022-12-31 FY2022 | 9957.32x | $0.00 | +3946.1% | |
2021-12-31 FY2021 | 246.09x | $0.07 | +1029.6% | |
2020-12-31 FY2020 | 21.79x | $0.86 | -82.4% | |
2019-12-31 FY2019 | 123.67x | $0.07 | — | |
2018-12-31 FY2018 | — | $-0.05 | — | |
2017-12-31 FY2017 | — | $-0.91 | — | |
2016-12-31 FY2016 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for InfuSystem Holdings, Inc. (INFU) measures how much investors pay for each dollar of the company's trailing earnings. INFU's current PE ratio of 23.07x is calculated by dividing its stock price of $9.03 by its TTM earnings per share of $0.39.
Frequently asked questions
INFU pe ratio · 6 questionsINFU's current PE ratio is 23.07x as of 2026-06-08, based on a stock price of $9.03 and TTM EPS of $0.39. Data sourced from Financial Modeling Prep via INFU's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · InfuSystem Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08